EDUCATION

Undergraduate Degree

  • University of Notre Dame , 1991 , Notre Dame , IN

Medical School

  • Tulane University School of Medicine , 1995 & 2001 , New Orleans , LA

Internship

  • Tulane University Health Sciences Center , 1995 , New Orleans , LA

Residency

  • Tulane University Health Sciences Center , 1996 , New Orleans , LA

Fellowship

Critical Care
  • Tulane University , 2003 , New Orleans , LA

Fellowship

Pediatric Surgery
  • Boston Children's Hospital , 2004 , Boston , MA

CERTIFICATIONS

  • American Board of Surgery, Pediatric Surgery
  • American Board of Surgery, Surgical Critical Care

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2021 Sep; 155:216-226. View abstract
  2. Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer. 2021 Jun; 68 Suppl 4:e29112. View abstract
  3. Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2021 May 04; 113(5):588-596. View abstract
  4. Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol. J Clin Oncol. 2021 Aug 01; 39(22):2463-2473. View abstract
  5. Neonatal Malignant Disorders: Germ Cell Tumors. Clin Perinatol. 2021 03; 48(1):147-165. View abstract
  6. Management of Adrenal Tumors in Pediatric Patients. Surg Oncol Clin N Am. 2021 Apr; 30(2):275-290. View abstract
  7. Epidemiology of abdominal wall and groin hernia repairs in children. Pediatr Surg Int. 2021 May; 37(5):587-595. View abstract
  8. Opioid Prescription Patterns for Children Following Laparoscopic Appendectomy. Ann Surg. 2020 12; 272(6):1149-1157. View abstract
  9. Training in pediatric surgical critical care. Curr Opin Pediatr. 2020 10; 32(5):694-697. View abstract
  10. The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatr Blood Cancer. 2020 10; 67(10):e28559. View abstract
  11. Making the most of small samples: Optimization of tissue allocation of pediatric solid tumors for clinical and research use. Pediatr Blood Cancer. 2020 09; 67(9):e28326. View abstract
  12. Imaging features of pathologically proven pediatric splenic masses. Pediatr Radiol. 2020 08; 50(9):1284-1292. View abstract
  13. Incidence of and risk factors for late cholecystectomy in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Eur J Cancer. 2020 07; 133:4-13. View abstract
  14. Comparison of Military Health System Data Repository and American College of Surgeons National Surgical Quality Improvement Program-Pediatric. BMC Pediatr. 2019 11 08; 19(1):419. View abstract
  15. Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer. 2019 11 01; 125(21):3873-3881. View abstract
  16. Therapeutic Impact and Complications Associated with Surgical Lung Biopsy after Allogeneic Hematopoietic Stem Cell Transplantation in Children. Biol Blood Marrow Transplant. 2019 11; 25(11):2181-2185. View abstract
  17. Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee. J Pediatr Surg. 2020 Apr; 55(4):655-659. View abstract
  18. Geographic distance to pediatric surgical care within the continental United States. J Pediatr Surg. 2019 Jun; 54(6):1112-1117. View abstract
  19. Multicenter pre-operative assessment of pediatric ovarian malignancy. J Pediatr Surg. 2019 Sep; 54(9):1921-1925. View abstract
  20. Clinical features and outcomes of spitzoid proliferations in children and adolescents. Br J Dermatol. 2019 08; 181(2):366-372. View abstract
  21. Time versus treatment: interpreting longitudinal data analysis of treprostinil. J Pediatr. 2019 03; 206:304-305. View abstract
  22. Nanoscale Bupivacaine Formulations To Enhance the Duration and Safety of Intravenous Regional Anesthesia. ACS Nano. 2019 01 22; 13(1):18-25. View abstract
  23. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2018 12; 19(12):1590-1601. View abstract
  24. Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2018 Sep 14; JCO2018784595. View abstract
  25. Another point of view on 2017 PRETEXT: reply to Pariente et al. Pediatr Radiol. 2018 11; 48(12):1820-1822. View abstract
  26. Incidence and risk factors for sepsis after childhood splenectomy. J Pediatr Surg. 2019 Jul; 54(7):1445-1448. View abstract
  27. Pediatric pancreatic neoplasms: The time is nigh for collaboration across continents. Pediatr Blood Cancer. 2018 Oct; 65(10):e27264. View abstract
  28. Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2018 06 01; 36(16):1571-1578. View abstract
  29. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560. View abstract
  30. Hernia recurrence following inguinal hernia repair in children. J Pediatr Surg. 2018 Nov; 53(11):2214-2218. View abstract
  31. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol. 2018 04; 48(4):536-554. View abstract
  32. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. J Clin Oncol. 2017 Oct 20; 35(30):3465-3473. View abstract
  33. The role of thymectomy in the treatment of juvenile myasthenia gravis: a systematic review. Pediatr Surg Int. 2017 Jun; 33(6):683-694. View abstract
  34. Malignant glomus tumors of the head and neck in children and adults: Evaluation and management. Laryngoscope. 2017 12; 127(12):2873-2882. View abstract
  35. Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic. J Clin Oncol. 2017 Feb 10; 35(5):523-528. View abstract
  36. Pediatric/"Wildtype" gastrointestinal stromal tumors. Semin Pediatr Surg. 2016 Oct; 25(5):305-310. View abstract
  37. Safety and cost-effectiveness of port removal outside of the operating room among pediatric patients. J Pediatr Surg. 2016 Nov; 51(11):1891-1895. View abstract
  38. Safety of peritoneal and pleural drain placement in pediatric stem cell transplant recipients with severe veno-occlusive disease. Pediatr Transplant. 2016 Aug; 20(5):687-91. View abstract
  39. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2016 Jul 01; 2(7):922-8. View abstract
  40. Preoperative risk stratification of children with ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1507-12. View abstract
  41. Poor adherence to staging guidelines for children with malignant ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1513-7. View abstract
  42. Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection. Pediatr Dev Pathol. 2016 Sep/Oct; 19(5):401-408. View abstract
  43. Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2015 Sep 10; 33(26):2893-900. View abstract
  44. Analysis of submitted abstracts for the American Academy of Pediatrics, Section on Surgery, National Conference (AAP SoSU). J Pediatr Surg. 2015 Jun; 50(6):1058-61. View abstract
  45. Sedation and analgesia in the ICU. Semin Pediatr Surg. 2015 Feb; 24(1):37-46. View abstract
  46. Surgical consultation and intervention during pediatric hematopoietic stem cell transplantation. Pediatr Transplant. 2014 Dec; 18(8):875-81. View abstract
  47. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis. JAMA Neurol. 2014 May; 71(5):575-80. View abstract
  48. Factors associated with survival in patients who undergo peritoneal dialysis catheter placement following cardiac surgery. J Pediatr Surg. 2013 Jun; 48(6):1269-76. View abstract
  49. Characterizing peritoneal dialysis catheter use in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2013 Aug; 146(2):334-8. View abstract
  50. Fetal and neonatal germ cell tumors. Semin Fetal Neonatal Med. 2012 Aug; 17(4):222-230. View abstract
  51. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. J Steroid Biochem Mol Biol. 2012 Oct; 132(1-2):186-93. View abstract
  52. Electrospun drug-eluting sutures for local anesthesia. J Control Release. 2012 Aug 10; 161(3):903-9. View abstract
  53. Pediatric gastrointestinal stromal tumor. Semin Pediatr Surg. 2012 Feb; 21(1):31-43. View abstract
  54. Adrenal cortical tumors in children: factors associated with poor outcome. J Pediatr Surg. 2011 Jun; 46(6):1201-7. View abstract
  55. Facilitators of quality breast cancer screening and diagnosis in an urban environment. J Clin Oncol. 2011 May 20; 29(15_suppl):e16584. View abstract
  56. BRCA+ test result impact and timing on surgical treatment decisions for patients with breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):626. View abstract
  57. Barriers to implementing primary HER2 FISH testing. J Clin Oncol. 2011 May 20; 29(15_suppl):e16642. View abstract
  58. Oncology Medical Home to address challenges in breast cancer care delivery. J Clin Oncol. 2011 May 20; 29(15_suppl):e16641. View abstract
  59. Prophylactic oophorectomy for patients with breast cancer with BRCA results. J Clin Oncol. 2011 May 20; 29(15_suppl):1533. View abstract
  60. Preoperative MDCT evaluation of congenital lung anomalies in children: comparison of axial, multiplanar, and 3D images. AJR Am J Roentgenol. 2011 May; 196(5):1040-6. View abstract
  61. Nanotechnology for surgeons. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 May-Jun; 3(3):223-8. View abstract
  62. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer. 2011 Mar; 50(3):146-53. View abstract
  63. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. Int J Oncol. 2010 Sep; 37(3):541-50. View abstract
  64. Primary lung tumors in children and adolescents: a 90-year experience. J Pediatr Surg. 2010 Jun; 45(6):1090-5. View abstract
  65. Adolescent gynecomastia: not only an obesity issue. Ann Plast Surg. 2010 May; 64(5):688-90. View abstract
  66. Childhood pancreatic tumors: a single institution experience. J Pediatr Surg. 2009 Dec; 44(12):2267-72. View abstract
  67. In utero diagnosis of congenital pyloric atresia in a single twin using MRI and ultrasound. J Pediatr Surg. 2009 Nov; 44(11):e21-4. View abstract
  68. H-type rectovaginal fistula in a patient with bilateral single ectopic ureters. J Pediatr Surg. 2009 Oct; 44(10):e27-30. View abstract
  69. Reduced size liver transplantation from a donor supported by a Berlin Heart. Am J Transplant. 2009 Nov; 9(11):2641-3. View abstract
  70. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg. 2009 Jun; 44(6):1072-5; discussion 1075-6. View abstract
  71. Outcomes after the Ladd procedure in patients with heterotaxy syndrome, congenital heart disease, and intestinal malrotation. J Pediatr Surg. 2009 Jun; 44(6):1089-95; discussion 1095. View abstract
  72. Mesenteric lipoblastoma presenting as a segmental volvulus. J Pediatr Surg. 2009 Feb; 44(2):e25-8. View abstract
  73. Use of a distal arteriovenous fistula in a complex vascular reconstruction after resection of an osteosarcoma in a high-risk child. J Pediatr Surg. 2009 Feb; 44(2):459-63. View abstract
  74. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res. 2008; 10(6):R105. View abstract
  75. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J Pediatr Surg. 2008 Dec; 43(12):2297-300. View abstract
  76. A familial case of pleuropulmonary blastoma. Eur J Pediatr Surg. 2008 Jun; 18(3):192-4. View abstract
  77. Pediatric pulmonary tumors: primary and metastatic. Semin Pediatr Surg. 2008 Feb; 17(1):17-29. View abstract
  78. Pediatric Pulmonary Tumors. Seminars in Pediatric Surgery. 2008; in press.. View abstract
  79. Congenital Esophageal Disorders. Operative Thoracic Surgery. 2008; in press/submitted.. View abstract
  80. A Familial Case of Pleuropulmonary Blastoma. European Journal of Pediatric Surgery. 2008; in press.. View abstract
  81. Surgical Aspects of Pediatric Oncology. Nathan and Oski’s Pediatric Hematology and Oncology. 2008; in press/submitted.. View abstract
  82. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Mol Endocrinol. 2006 May; 20(5):971-83. View abstract
  83. P38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein1. Molecular Endocrinology,. 2006; 20(5):971-983.. View abstract
  84. PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. Int J Oncol. 2005 Mar; 26(3):763-8. View abstract
  85. Mechanical and antibacterial bowel preparation in colon and rectal surgery. Chemotherapy. 2005; 51 Suppl 1:115-21. View abstract
  86. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators. Surgery. 2004 Aug; 136(2):346-54. View abstract
  87. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Int J Oncol. 2004 Jun; 24(6):1473-80. View abstract
  88. Solid and papillary epithelial neoplasm of the pancreas. J Surg Oncol. 2004 Mar 15; 85(4):193-8. View abstract
  89. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood). 2003 Oct; 228(9):995-1003. View abstract
  90. Guidelines for withholding or termination of resuscitation in prehospital traumatic cardiopulmonary arrest. J Am Coll Surg. 2003 Mar; 196(3):475-81. View abstract
  91. Sensitization of Apoptotically Resistant Breast Carcinoma Cells to TNF and TRAIL by Inhibition of P38 Mitogen-Activated Protein Kinase Signaling. Proceedings of the Society of Surgical Oncology. 2003. View abstract
  92. Guidelines for withholding or termination of resuscitation in prehospital cardiopulmonary arrest. Journal of American College of Surgeons,. 2003; 196(3):475-81.. View abstract
  93. Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem. Ann Surg Oncol. 2002 Oct; 9(8):738-44. View abstract
  94. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery. 2002 Aug; 132(2):293-301. View abstract
  95. ATLS training: a novel approach. Bull Am Coll Surg. 2002 Apr; 87(4):15-9. View abstract
  96. Advanced Trauma Life Support Training: A novel approach. Bulletin of the American College of Surgeons,. 2002; 87(4):15-19.. View abstract
  97. Therapy-induced leukemias and myelodysplastic syndromes following breast cancer treatment. Ann Surgical Oncology. 2002; 9(8):738-744. View abstract
  98. Identification of mitogen-activated protein kinase kinase 5 (mek5) as a chemoresistance pathway in MCF-7 cells using gene expression microarray. Basic Science Plenary Session, Proceedings of the Society of University Surgeons. 2002. View abstract
  99. Identification of mitogen-activated protein kinase kinase 5 (MEK5) as a chemoresistance pathway in MCF-7 cells using gene expression microarray. Surgery,. 2002; 132(2):292-301.. View abstract
  100. Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. J Steroid Biochem Mol Biol. 2001 Nov; 78(5):409-18. View abstract
  101. NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery. 2001 Aug; 130(2):143-50. View abstract
  102. Esophageal carcinosarcoma. J Gastrointest Surg. 2001 Jul-Aug; 5(4):414-7. View abstract
  103. Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int J Oncol. 2001 Jul; 19(1):129-35. View abstract
  104. Oestrogen-mediated suppression of TNF-induced apoptosis in MCF-7 cells:subversion of Bcl-2 by antioestrogens. Journal of Ster Biochemistry Mol Biol.,. 2001; 78(5):409-418.. View abstract
  105. NF-kappa â-mediated chemoresistance in breast cancer cells. Proceedings of the Society of University Surgeons. 2001. View abstract
  106. Pre-hospital DNR Protocol: An idea whose time has arrived. Winner, Clinical Trauma Paper Competition. Louisiana State Committee on Trauma. Resident Paper Competition. 2001. View abstract
  107. Identification and analysis of molecular mechanisms of chemoresistance in human breast carcinoma cells. 2001. View abstract
  108. Identification of chemoresisstance targets in MCF-7 cells using gene microarray. Proceedings of the Society of Surgical Oncology. 2001. View abstract
  109. Esophageal carcinosarcoma. Journal of Gastrointestinal Surgery. 2001; 5(4):414-417.. View abstract
  110. Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. Int J Oncol. 2000 Jun; 16(6):1179-87. View abstract
  111. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem Biophys Res Commun. 2000 May 10; 271(2):342-5. View abstract
  112. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J Biol Chem. 2000 Mar 31; 275(13):9628-35. View abstract
  113. Modulation of apoptotic pathways for therapeutic advantage: MCF-7 cells as a model system. Proceedings of the 5th Annual Multidisciplinary Symposium on Breast Disease. 2000. View abstract
  114. Modulation of apoptotic pathways for therapeutic advantage in breast cancer. Proceedings of the American Society for Pharmacology and Experimental Therapeutics. 2000; 14(A1516). View abstract
  115. Differences in protein kinase C and estrogen receptor á, â expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. International Journal of Oncology,. 2000; 16(6):1179-1187.. View abstract
  116. Phosphatidylinositol 3-kinase/Akt mediated regulation of NF-êB signaling events as a mechanism for suppression of TNF-induced apoptosis. Biochemistry Biophysiology Res Commun,. 2000; 271(2):342-345.. View abstract
  117. Characterization of chemoresistance of MCF-7/ADR breast cancer cells. Proceedings of the Society of University Surgeons, Residents’ Conference. 2000. View abstract
  118. MCF-7/ADR breast cancer cell chemonresistance. Proceedings of the American Association of Cancer Research. 2000. View abstract
  119. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res. 1998 Nov 01; 58(21):4940-6. View abstract
  120. Phorbol ester and insulin-like growth factor-I suppression of TNF-á-induced apoptosis through a phosphatidylinositol-3-kinase mediated inhibition of ceramide formation and caspase activation. Proceedings of the American Association for Cancer Research special conference on Molecular Mechanisms of Apoptosis Regulation. 1998. View abstract
  121. Breast Leiomyoma. Journal of Louisiana State Medical Society. 1998; 150(8):367-370.. View abstract
  122. Differences in susceptibility to tumor necrosis factor á-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Research,. 1998; 58:4940-4946.. View abstract
  123. MCF-7 breast cancer cell variants display differences in tumor necrosis factor á-included apoptosis. Proceedings of the Society of University Surgeons, Residents’ Conference. 1998. View abstract
  124. Cross-talk between phosphatidylinositol-3 kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. Journal of Biology and Chemistry,. 1998; 275(13):9628-9635.. View abstract
  125. Differences in susceptibility to tumor necrosis factor- á-induced apoptosis among MCF-7 breast cancer cell variants. Proceedings of the American Association for Cancer Research. 1998. View abstract
  126. Overlapping and nonoverlapping cortical projections to cortex of the superior temporal sulcus in the rhesus monkey: double anterograde tracer studies. J Comp Neurol. 1996 Jun 24; 370(2):173-90. View abstract
  127. Parvalbumin staining delineates superior temporal polymodal cortex in Macaca mulatta. Proceedings of the Society of Neuroscience. 1993; (19):972. View abstract
  128. Organization of cortical projections to the superior temporal polymodal cortex of the rhesus: double anterograde labeling studies. Proceedings of the Society of Neuroscience. 1992; (18):295. View abstract
  129. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg. 1989 Feb; 97(2):194-203. View abstract
  130. Preoperative three-dimensional reconstruction of the heart and great vessels in patients with congenital heart disease. Technique and initial results. J Thorac Cardiovasc Surg. 1988 Sep; 96(3):464-73. View abstract
  131. Replacement of cardiac valves in children. J Pediatr. 1972 Jun; 80(6):980-7. View abstract
  132. Mexed-type total anomalous pulmonary venous drainage. Report of a successful surgical correction and review of the literature. J Thorac Cardiovasc Surg. 1972 Jan; 63(1):164-70. View abstract